Pharma Giants Make Big Moves in Multi-Billion Dollar Deals
Private equity firm KKR made headlines this week by acquiring Integer Holdings in an all-cash deal worth $5.7 billion. The acquisition is a significant move for KKR, demonstrating its commitment to investing in healthcare and life sciences.
Eli Lilly also made major moves, announcing plans to acquire three vaccine biotechs - Curevo Vaccine, LimmaTech Biologics, and Vaccine Company - for up to $3.8 billion. This acquisition is part of Eli Lilly's efforts to expand its vaccine portfolio and address emerging global health threats.
Other notable deals include Procter & Gamble's acquisition of supplement maker Thorne for $3.8 billion and Jazz Pharmaceuticals' deal to buy Actio Biosciences for $820 million upfront, plus up to $500 million in regulatory and sales-related milestone payments.